Fidelity Investments’s VivoSim Labs VIVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25
Closed -$73 5665
2025
Q3
$73 Buy
25
+15
+150% +$36 ﹤0.01% 5221
2025
Q2
$15 Buy
+10
New +$18 ﹤0.01% 5279
2024
Q3
Sell
-38
Closed -$347 5772
2024
Q2
$347 Buy
38
+34
+850% +$401 ﹤0.01% 4891
2024
Q1
$52 Buy
+4
New +$50 ﹤0.01% 5030
2023
Q4
Sell
-1
Closed -$15 5690
2023
Q3
$15 Hold
1
﹤0.01% 5137
2023
Q2
$20 Hold
1
﹤0.01% 5181
2023
Q1
$31 Hold
1
﹤0.01% 5050
2022
Q4
$20 Sell
1
-1
-50% -$20 ﹤0.01% 5130
2022
Q3
$0 Hold
2
﹤0.01% 5494
2022
Q2
$0 Buy
+2
New +$62 ﹤0.01% 5589
2020
Q4
Sell
-21
Closed -$2K 4349
2020
Q3
$2K Buy
+21
New +$2.7K ﹤0.01% 3506
2020
Q2
Sell
-31
Closed -$3K 4250
2020
Q1
$3K Buy
+31
New +$2.5K ﹤0.01% 3362
2016
Q2
Sell
-66
Closed -$34K 2709
2016
Q1
$34K Sell
66
-5,372
-99% -$2.73M ﹤0.01% 2650
2015
Q4
$3.25M Hold
5,438
﹤0.01% 2313
2015
Q3
$3.5M Hold
5,438
﹤0.01% 2279
2015
Q2
$4.92M Hold
5,438
﹤0.01% 2244
2015
Q1
$4.62M Hold
5,438
﹤0.01% 2242
2014
Q4
$9.46M Sell
5,438
-1,427
-21% -$2.19M ﹤0.01% 2021
2014
Q3
$10.5M Hold
6,865
﹤0.01% 1993
2014
Q2
$13.8M Sell
6,865
-1,460
-18% -$2.45M ﹤0.01% 1950
2014
Q1
$15.3M Hold
8,325
﹤0.01% 1870
2013
Q4
$22.1M Buy
+8,325
New +$16.3M ﹤0.01% 1667

Other funds holding VIVS

Fidelity Investments's VIVS Position: Q4 2025 in Review

Fidelity Investments sold out of VivoSim Labs (VIVS) in Q4 2025, closing a stake of 25 shares — an estimated $73 sold.

Fidelity Investments first reported a position in VIVS in Q4 2013 and held it in 22 quarters. The position peaked at $22.1M in Q4 2013. 27 funds tracked by Wall St. Rank hold VIVS as of Q4 2025.

  • Fidelity Investments reported no remaining VivoSim Labs position as of Q4 2025 after selling out during the quarter.
  • Fidelity Investments sold 25 VivoSim Labs shares in Q4 2025, an estimated $73.
  • Fidelity Investments first reported a position in VivoSim Labs in Q4 2013 and held it in 22 quarters.
  • Fidelity Investments's VivoSim Labs position peaked at $22.1M in Q4 2013.
  • 27 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2025.

Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.